Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines

Donaldson, MG and Cawthon, PM and Lui, LY and Schousboe, JT and Ensrud, KE and Taylor, BC and Cauley, JA and Hillier, TA and Dam, TT and Curtis, JR and Black, DM and Bauer, DC and Orwoll, ES and Cummings, SR (2010) Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US national osteoporosis foundation guidelines. Journal of Bone and Mineral Research, 25 (7). 1506 - 1511. ISSN 0884-0431

[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

The new US National Osteoporosis Foundation's (NOF's) Clinician's Guide to Prevention and Treatment of Osteoporosis includes criteria for recommending pharmacologic treatment based on history of hip or vertebral fracture, femoral neck or spine bone mineral density (BMD) T-scores of -2.5 or less, and presence of low bone mass at the femoral neck or spine plus a 10-year risk of hip fracture of 3% or greater or of major osteoporotic fracture of 20% or greater. The proportion of men who would be recommended for treatment by these guidelines is not known. We applied the NOF criteria for treatment to men participating in the Osteoporotic Fractures in Men Study (MrOS). To determine how the MrOS population differs from the general US population of Caucasian men aged 65 years and older, we compared men in MrOS with men who participated in the National Health and Nutrition Examination Survey (NHANES) III on criteria included in the NOF treatment guidelines that were common to both cohorts. Compared with NHANES III, men in MrOS had higher femoral neck BMD values. Application of NOF guidelines to MrOS data estimated that at least 34% of US white men aged 65 years and older and 49% of those aged 75 years and older would be recommended for drug treatment. Application of the new NOF guidelines would result in recommending a very large proportion of white men in the United States for pharmacologic treatment of osteoporosis, for many of whom the efficacy of treatment is unknown. © 2010 American Society for Bone and Mineral Research.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Donaldson, MG
Cawthon, PM
Lui, LY
Schousboe, JT
Ensrud, KE
Taylor, BC
Cauley, JAJCauley@edc.pitt.eduJCAULEY
Hillier, TA
Dam, TT
Curtis, JR
Black, DM
Bauer, DC
Orwoll, ES
Cummings, SR
Date: 1 July 2010
Date Type: Publication
Journal or Publication Title: Journal of Bone and Mineral Research
Volume: 25
Number: 7
Page Range: 1506 - 1511
DOI or Unique Handle: 10.1002/jbmr.55
Schools and Programs: Graduate School of Public Health > Epidemiology
Refereed: Yes
ISSN: 0884-0431
Date Deposited: 01 Dec 2015 15:08
Last Modified: 30 Oct 2018 13:56
URI: http://d-scholarship.pitt.edu/id/eprint/24240

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item